Analysis of Optimal Treatment Starting Time for Photothermal Therapy Through Analysis of Diffusion Behavior of Gold Nanoparticles
Donghyuk Kim,Hyunjung Kim
DOI: https://doi.org/10.2147/ijn.s452470
IF: 7.033
2024-04-04
International Journal of Nanomedicine
Abstract:Donghyuk Kim, Hyunjung Kim Department of Mechanical Engineering, Ajou University, Suwon-si, Gyeonggi-do, 16499, Korea Correspondence: Hyunjung Kim, Email Introduction: Due to its distinct advantage of non-invasive application in treatment, photothermal therapy (PTT) is being studied by many researchers to reduce the need for surgical incisions. It is characterized by the injection of nanoparticles into biological tissue as photothermal agents (PTAs) which diffuse within the tissue. In this study, the diffusion behavior of various doses of gold nanoparticles (AuNPs) injected into tumor tissues is analyzed and the effectiveness of PTT at each elapsed time after injection is confirmed by numerical analysis. Methods: The diffusion behavior of AuNPs within biological tissues is assessed using the convection-diffusion equation, while the temperature distribution is determined using the Pennes bioheat transfer equation. In addition, the effect of the diffusion behavior of AuNPs on the effectiveness of PTT is quantitatively confirmed by analyzing the temperature distribution in the medium through the apoptotic variable. Numerical simulation parameters are selected with doses ranging from 100 to 400 μg/mL, elapsed time after injection from 1 min to 24 h, and laser power ranging from 0 to 1 W. Results: After evaluating PTT's efficacy in every situation, it was discovered that a dosage of 100– 300 μg/mL produced the best therapeutic result, with the highest impact occurring 12 hours after injection. In contrast, when the dosage was 400 μg/mL, the highest therapeutic effect was achieved after 18 hours post-injection. Additionally, it was discovered that the ideal laser power at each injection dose was 0.22, 0.14, 0.12, and 0.12 W, respectively. Conclusion: The conditions required to achieve the optimal treatment effect at each dosage, presented here, are expected to accelerate the commercialization of PTT. Keywords: apoptosis, elapsed time after injection, gold nanoparticles, injection dose, photothermal therapy, thermal damage Photothermal therapy (PTT), an anti-cancer treatment technique that utilizes lasers, is being studied by many researchers due to its non-invasive nature. 1–3 Unlike conventional treatment techniques, PTT is performed without incisions, resulting in no bleeding, fast recovery, and no scarring. 4 The therapeutic mechanism of PTT is the photothermal effect, which refers to the conversion of light energy into heat energy. 5 Due to this photothermal effect, tumors are killed by increasing the temperature of the affected area irradiated by the laser. Biological tissues undergo different mechanisms of cell death depending on temperature. 6 From 43–50 °C, death occurs in the form of apoptosis, in which cells die on their own. At temperatures above 50 °C, death occurs in the form of both necrosis and leakage of intracellular contents, resulting in a risk of cancer metastasis. PTT utilizes a variety of laser wavelengths to achieve different temperatures in the target tissues. 7–9 Among these, lasers in the near-infrared region have the advantage of deep penetration, but the disadvantage that the amount of laser energy that can be absorbed by the medium is small and does not cause a sufficient temperature increase. 10,11 Due to these characteristics, if only near-infrared lasers are used, there is a possibility of unnecessary thermal damage due to the absorption of laser energy by healthy tissue as well as tumor tissue. To address this, photothermal agents (PTAs) are used to enhance the light absorption coefficient of tumor tissue. 12–14 PTAs, which enhance laser absorption at specific wavelengths by the phenomenon of localized surface plasmon resonance (LSPR), are largely manufactured from noble metal series and polymer series. 15 Each material comes with advantages and disadvantages, and its selection for treatment is determined by the specific circumstances. 16,17 Research on PTT is ongoing. Hu et al 18 created a supramolecular drug nanocarrier to co-deliver nitric oxide (NO) and the photothermal agent DCTBT with the NIR-II aggregation-induced emission (AIE) characteristic for mild-temperature PTT to improve the therapeutic efficacy, which is limited by cancer cells' thermotolerance. It was confirmed that NO was effectively released from the fabricated carrier, and reactive oxygen species (ROS) and high heat were generated when irradiated with 808 nm laser. It was also confirmed that the generated ROS reacted with NO to produce nitric oxide, which reduced the heat resistance of cancer cells. Cheong et al 19 confirmed the therapeutic effect by changing the heterogeneous distribution of gold nanorods (GNRs) in -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology